The vitamin K cycle

Journal of Thrombosis and Haemostasis : JTH
Darrel W Stafford

Abstract

Post-translational modification of glutamate to gamma carboxyl glutamate is required for the activity of vitamin K-dependent proteins. Carboxylation is accomplished by the enzyme gamma glutamyl carboxylase (GGCX) which requires the propeptide-containing substrate and three co-substrates: reduced vitamin K, CO2, and O2. Most propeptides bind tightly to GGCX and all of the Glu residues that will be modified are modified during one binding event. Complete carboxylation is thus dependent upon the rate of carboxylation and the dissociation rate constant of the substrate from the GGCX enzyme. If the propeptide is released before carboxylation is complete, partially carboxylated vitamin K-dependent proteins are produced. The rate of carboxylation is mainly controlled by the level of reduced vitamin K available for the reactions while the dissociation rate constant is dependent upon both the propeptide and the Gla domain of the substrate. In addition, there are allosteric effects that increase the rate of dissociation of the fully carboxylated substrates. Carboxylation requires the abstraction of a proton from the 4-carbon of glutamate by reduced vitamin K and results in the conversion of vitamin K to vitamin K epoxide. The vitamin K e...Continue Reading

References

Sep 16, 1992·Biochemical and Biophysical Research Communications·Y AkedoH Orimo
Mar 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·S M WuD W Stafford
Sep 30, 1988·Biochemical and Biophysical Research Communications·R B Silverman, D L Nandi
Dec 1, 1970·Archives of Biochemistry and Biophysics·R G Bell, J T Matschiner
Jan 15, 1994·The Biochemical Journal·H H ThijssenL T Vervoort
Dec 22, 1995·The Journal of Biological Chemistry·D P MorrisD W Stafford
Oct 1, 1996·The Journal of Clinical Investigation·K ChuK A High
Sep 22, 1998·Arteriosclerosis, Thrombosis, and Vascular Biology·P A PriceM K Williamson
Jan 28, 1999·Biochemical and Biophysical Research Communications·U YasarF Sjöqvist
Feb 15, 2001·Proceedings of the National Academy of Sciences of the United States of America·J D KulmanE W Davie
Apr 3, 2002·JAMA : the Journal of the American Medical Association·Mitchell K HigashiAllan E Rettie
Oct 26, 2002·The American Journal of Clinical Nutrition·Neil C BinkleyJohn W Suttie
Aug 16, 2003·The Journal of Biological Chemistry·Michelle M TabbBruce Blumberg
Feb 7, 2004·Nature·Tao LiDarrel W Stafford
Sep 15, 2004·Proceedings of the National Academy of Sciences of the United States of America·Mark A RishavyKathleen L Berkner

❮ Previous
Next ❯

Citations

Nov 11, 2011·European Journal of Clinical Pharmacology·Liat MlynarskyYoseph Caraco
Dec 17, 2011·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Bo HuZhangqun Ye
Sep 16, 2010·Current Treatment Options in Neurology·Maria I Aguilar, William D Freeman
Dec 19, 2009·Proceedings of the National Academy of Sciences of the United States of America·Rachel J DuttonDana Boyd
Jan 8, 2013·Antioxidants & Redox Signaling·Thomas Kieselbach
Nov 27, 2009·Pharmacogenetics and Genomics·Ryan P OwenRuss B Altman
Jul 21, 2007·Southern Medical Journal·Raja S VadlamudiHassan M Ismail
Aug 20, 2011·Circulation Research·Frank RutschRobert Terkeltaub
Mar 1, 2007·Blood·Aihua ZhuDavid Ginsburg
May 26, 2010·BMC Genetics·Juan C DíazMichael H Kohn
Oct 24, 2013·Lipids in Health and Disease·Xiayizha KamaliPeng-Yi He
Nov 17, 2012·Molecular Medicine·Virginia Pérez-AndreuConstantino Martínez
Nov 21, 2008·Pharmacogenomics·Christos N MarkatosAnthi Travlou
Jun 30, 2011·Hämostaseologie·M L L ChatrouL J Schurgers
May 16, 2013·American Journal of Respiratory and Critical Care Medicine·Pilar GallegoGregory Y H Lip
May 3, 2014·Evidence-based Complementary and Alternative Medicine : ECAM·Beikang GeZhong Zuo
Apr 30, 2014·Orphanet Journal of Rare Diseases·Mohammad J HosenOlivier M Vanakker
Jan 5, 2014·Cardiovascular Research·Henri M H SpronkHugo Ten Cate
Jun 19, 2014·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Bo HuGuo-Wei Shi
Feb 13, 2013·International Journal of Pediatrics·O M Vanakker, A De Paepe
Mar 1, 2011·Expert Opinion on Emerging Drugs·Gentian Denas, Vittorio Pengo
Oct 27, 2006·The FEBS Journal·Sassan Hafizi, Björn Dahlbäck
Oct 17, 2012·La Presse médicale·Laurent ChouchanaAgnès Lillo-Le Louet
Jan 17, 2014·Kidney International·Nadine KaeslerThilo Krüger
Apr 24, 2009·Kidney International·Thilo KruegerJürgen Floege
Apr 7, 2010·La Revue de médecine interne·C MoreauM-A Loriot
Mar 6, 2016·Annales de dermatologie et de vénéréologie·L GusdorfB Cribier
Feb 2, 2010·Early Human Development·Frank R Greer
Sep 12, 2015·Intractable & Rare Diseases Research·Barbara MarconiAnnamaria Offidani
Nov 4, 2009·Artery Research·Michael H KohnHans-Joachim Pelz

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.